Innoviz Technologies Ltd (INVZ) concluded trading on Thursday at a closing price of $0.79, with 3.85 million shares of worth about $3.04 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.07% during that period and on April 24, 2025 the price saw a gain of about 9.06%. Currently the company’s common shares owned by public are about 198.96M shares, out of which, 198.96M shares are available for trading.
Stock saw a price change of 25.66% in past 5 days and over the past one month there was a price change of 8.98%. Year-to-date (YTD), INVZ shares are showing a performance of -52.98% which decreased to -16.84% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.45 but also hit the highest price of $3.14 during that period. The average intraday trading volume for Innoviz Technologies Ltd shares is 7.39 million. The stock is currently trading 27.32% above its 20-day simple moving average (SMA20), while that difference is up 12.12% for SMA50 and it goes to -10.59% lower than SMA200.
Innoviz Technologies Ltd (NASDAQ: INVZ) currently have 198.96M outstanding shares and institutions hold larger chunk of about 30.63% of that.
The stock has a current market capitalization of $157.18M and its 3Y-monthly beta is at 0.78. It has posted earnings per share of -$0.57 in the same period. It has Quick Ratio of 2.73 while making debt-to-equity ratio of 0.37. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INVZ, volatility over the week remained 6.92% while standing at 8.81% over the month.
Stock’s fiscal year EPS is expected to rise by 35.96% while it is estimated to increase by 19.18% in next year. EPS is likely to grow at an annualized rate of 25.57% for next 5-years, compared to annual growth of -463.21% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Rosenblatt on December 20, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. On July 11, 2024, Goldman Downgrade their recommendations, while on October 25, 2022, Rosenblatt Initiated their ratings for the stock with a price target of $5. Stock get a Buy rating from Berenberg on September 28, 2022.
